Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:14 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 265–288 of 396 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Foot Ulcers, Diabetic Clear all

Conditions: Diabetic Foot Ulcer
Interventions: Lavior Diabetic Wound Gel, Smith & Nephew Solosite Gel Hydrogel Wound Dressing; Drug
Lead sponsor: Lavior Pharma Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Diabetic Foot Ulcer
Interventions: MIST Therapy, SOC - Standard of Care; Device · Other
Lead sponsor: Celleration, Inc.; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Diabetic Foot Ulcers, Osteomyelitis
Interventions: DFU; Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 89 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2023
U.S. locations: 2
States / cities: Dallas, Texas

Conditions: Diabetic Foot Ulcer
Interventions: AutoloGel, Usual and Customary Care; Device · Other
Lead sponsor: Cytomedix; Industry
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Hattiesburg, Mississippi

Conditions: Diabetic Foot
Interventions: SkinTE, Control; Biological · Other
Lead sponsor: PolarityTE; Industry
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 13
States / cities: Fresno, California • Los Angeles, California • Hollywood, Florida + 8 more

Conditions: Diabetic Neuropathies, Diabetic Foot, Diabetic Retinopathy
Interventions: no intervention; Other
Lead sponsor: VisionQuest Biomedical LLC; Industry
Eligibility: 35 Years to 76 Years
Enrollment: 331 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Diabetic Foot Infections
Interventions: Bisphosphocin Nu-3, Placebo; Drug
Lead sponsor: Lakewood-Amedex Inc; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 3
States / cities: San Francisco, California • Oldsmar, Florida • Franklin, Tennessee

Conditions: Type II Diabetes
Interventions: Sitagliptin, Placebo; Drug
Lead sponsor: Georgetown University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Foot Ulcer, Diabetes
Interventions: KC-002, Conventional Wound Therapy; Device · Other
Lead sponsor: KeraCure; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 21
States / cities: Montgomery, Alabama • Phoenix, Arizona • Tucson, Arizona + 18 more

Conditions: Non-infected Diabetic Foot Ulcer, Diabetic Foot, Diabetic Wound, Diabetic Foot Ulcer, Non-ischemic Diabetic Foot Ulcer
Interventions: BR-AM, Standard Care; Other
Lead sponsor: BioStem Technologies; Industry
Eligibility: 18 Years and older
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 17
States / cities: Guntersville, Alabama • Mesa, Arizona • Tucson, Arizona + 14 more

Conditions: Diabetic Foot Ulcer, Venous Leg Ulcer, Ulcer Foot, Leg Ulcer
Interventions: Standard of Care-DFU, AmnioCore - DFU, Amnio Quad-Core - DFU, Standard of Care-VLU, Amnio Tri-Core - VLU, Amniocore Pro +; Other
Lead sponsor: Stability Biologics; Industry
Eligibility: 21 Years and older
Enrollment: 324 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Circleville, Ohio

Conditions: Diabetic Foot Ulcer
Interventions: COMS One device, Sham device; Device
Lead sponsor: Piomic Medical; Industry
Eligibility: 22 Years to 90 Years
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 30
States / cities: Mesa, Arizona • Tucson, Arizona • Castro Valley, California + 23 more

Conditions: Diabetic Foot, Diabetic Foot Ulcer, Diabetes, Diabetes Mellitus, Infected Wound, Infected Ulcer of Skin
Interventions: Phototherapy, Debridement Surgery and Wound Dressing; Device · Procedure
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Diabetic Foot Ulcers
Interventions: V.A.C. Negative Pressure Wound Therapy System; Device
Lead sponsor: KCI USA, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 6
States / cities: New Haven, Connecticut • South Miami, Florida • Bethlehem, Pennsylvania + 2 more

Conditions: Diabetic Foot Ulcer
Interventions: gentamicin-collagen sponge, Levofloxacin; Drug
Lead sponsor: Innocoll; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Pasadena, Maryland

Conditions: Diabetic Foot Ulcers
Interventions: Total Contact Cast, Instant Total Contact Cast (ITCC), Removable Cast Walker (RCW); Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 4
States / cities: Tucson, Arizona • Dallas, Texas • Temple, Texas

Conditions: Foot Ulcer, Diabetic
Interventions: DERMASEAL, Plasma Film, Standard of Care; Combination Product · Biological · Other
Lead sponsor: Vitruvian Medical Devices, Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 4
States / cities: Fresno, California • South Miami, Florida • Boardman, Ohio + 1 more

Conditions: Foot Ulcer, Diabetic
Interventions: Topical Dermacyn, Topical Dermacyn and Levofloxacin, Topical Saline and Levofloxacin; Drug
Lead sponsor: Oculus Innovative Sciences, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007
U.S. locations: 16
States / cities: Tucson, Arizona • La Jolla, California • Los Angeles, California + 13 more

Conditions: Diabetic Foot Ulcer, Diabetes Mellitus, Wound
Interventions: Conventional bacterial culture, Rapid diagnostic group using mNGS technology; Diagnostic Test · Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Ann Arbor, Michigan

Conditions: Diabetic Foot Ulcers
Interventions: Prevention Diabetic Foot Ulcer; Device
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 750 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2002
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Diabetic Foot Ulcer
Interventions: No intervention-retrospective study; Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 89 Years
Enrollment: 3,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Diabetic Foot Ulcer
Interventions: Podimetrics SmartMat; Device
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Diabetic Foot Ulcers, Wound Care
Interventions: AmnioClear™ Human Allograft Amniotic Membrane; Biological
Lead sponsor: Liventa Bioscience; Industry
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Diabetic Foot Ulcers (DFU), Foot Ulcer Chronic, Ulcer, Diabetic Foot Ulcer
Interventions: Blue Drop Foot Scanner; Other
Lead sponsor: Applied Biologics, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 50 participants
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Clinton Township, Michigan

Search by objective public record fields.

Restoring Tissue and Evaluating Novel Treatments for Efficacy in Wounds

RESPOND Restoring Equilibrium and Wound Stimulation to Promote Healing Of Non-healing DFUs

UT Southwestern Diabetic Foot Ulcers (DFU) and Osteomyelitis (DFO) Recruitment Database, Data and Tissue Repository

Efficacy of AutoloGel Therapy to Usual and Customary Care in Wagner gd 1 and 2 Diabetic Foot Ulcers.

Multi-Center, Prospective, Randomized Controlled Trial Evaluating SkinTE® in the Treatment of Wagner 2 DFUs

Thermal Screening for Early Diabetic Peripheral Neuropathy (DPN)

Topically Applied Bisphosphocin Nu-3 on Infected Diabetic Ulcers of Subjects With Type I or II Diabetes Mellitus

Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers

Safety and Efficacy Study of an Interactive Wound Dressing (KC002) for the Treatment of Diabetic Foot Ulcers

Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AM

Modified Multi-Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of DFU and VLUs

Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers

Adjunctive Phototherapy Treatment of Infected Diabetic Ulcers

Evaluating the Ease of Use of a VAC GranuFoam Bridge Dressing on Diabetic Foot Ulcers Receiving VAC Negative Pressure Wound Therapy

Safety and Efficacy of an Antibiotic Sponge in Diabetic Patients With a Mild Infection of a Foot Ulcer

Instant Total Contact Cast to Heal Diabetic Foot Ulcers

Study to Assess the Safety of DERMASEAL for Diabetic Foot Ulcers

Pilot Study of the Safety and Clinical Efficacy of Topical Dermacyn™ Wound Care to Treat Mild Diabetic Foot Infections

Diabetic Foot Ulcer (DFU) Rapid Pathogen Identification

A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk

The Effect of Implementing a Limb Loss Prevention Program on Amputation Rates

Improving DFU Outcomes: Early Detection of Foot Ulcers Using Novel Technology

A Randomized Comparison of AmnioClear™ Human Allograft Amniotic Membrane vs. Moist Wound Dressing in the Treatment of Diabetic Wounds

Evaluating the Durability of Closure for Diabetic Foot Ulcers Following a Randomized, Controlled, Modified Platform Trial.